Skip to Content

We invite you to try out our new beta eCFR site at https://ecfr.federalregister.gov. We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the 'Feedback' button on the bottom right of each page!

Correction

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning Monoclonal Antibody Against Ricin A Chain

A Correction by the Army Department, the Federal Communications Commission, the U.S. Customs and Border Protection, the Justice Department, and the National Highway Traffic Safety Administration on 04/24/2003

Document Details

Information about this document as published in the Federal Register.

Printed version:
PDF
Publication Date:
04/24/2003
Agencies:
Department of the Army
Federal Communications Commission
Bureau of Customs and Border Protection
Department of Justice
National Highway Traffic Safety Administration
Document Type:
Correction
Document Citation:
68 FR 20225
Page:
20225 (1 page)
Agency/Docket Numbers:
IB Docket No. 98-172, FCC 02-317
AAG/A Order No. 012-2003
Docket No. NHTSA 2001-8677
Notice 4
RIN:
2127-AI92
Document Number:
C3-9470
Document Details
Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Page views:
111
as of 04/20/2021 at 12:15 am EDT
Document Statistics
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 20225 End Preamble Start Supplemental Information

Correction

In notice document 03-9470 beginning on page 18972 in the issue of Thursday, April 17, 2003, make the following corrections:

1. On page 18972, in the third column, in the second line from the bottom, “100 μg/mL”, should read “100 ηg/mL”.

2. On page 18973, in the first column, in the second line, “1000 μg/mL”, should read “1000 ηg/mL”.

End Supplemental Information Start Preamble End Preamble Start Supplemental Information

Correction

In rule document 03-7322 beginning on page 16962 in the issue of Tuesday, April 8, 2003, make the following corrections:

[Corrected]

1. On page 16967, in the first column, in § 74.551, in amendatory instruction 13, in the second line, “(d)” should read “(b)”.

2. On the same page, in the second column, also in §74.551, paragraph heading “(d)” should read “(b)”.

End Supplemental Information Start Preamble End Preamble Start Supplemental Information

Correction

In notice document 03-9405 beginning on page 18994 in the issue of Thursday, April 17, 2003, make the following correction:

On page 18995, in the first column, under the heading DATES, in the sixth line, “May 19, 2003” should read, “June 18, 2003”.

End Supplemental Information Start Preamble End Preamble Start Supplemental Information

Correction

In rule document 03-9324 beginning on page 19148 in the issue of April 18, 2003, make the following correction:

On page 19149, in the second column, under List of Subjects in 28 CFR Part 16, in the second paragraph, in the fourth line “3003” should read “2003”.

End Supplemental Information Start Preamble End Preamble Start Supplemental Information

Correction

In rule document 03-9199 beginning on page 18136 in the issue of Tuesday, April 15, 2003, make the following correction:

[Corrected]

On page 18143, in the second column, in §579.28, in paragraph (c), in the second line, “No” should read “(1) No”.

End Supplemental Information

[FR Doc. C3-9470 Filed 4-23-03; 8:45 am]

BILLING CODE 1505-01-D

[FR Doc. C3-7322 Filed 4-23-03; 8:45 am]

BILLING CODE 1505-01-D

[FR Doc. C3-9405 Filed 4-23-03; 8:45 am]

BILLING CODE 1505-01-D

[FR Doc. C3-9324 Filed 4-23-03; 8:45 am]

BILLING CODE 1505-01-D

[FR Doc. C3-9199 Filed 4-23-03; 8:45 am]

BILLING CODE 1505-01-D

Published Document